Knowledge, perceptions and information about hormone therapy (HT) among menopausal women: A systematic review and meta-synthesis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Tao, MinFang ^a   Teng, YinCheng ^a   Shao, HongFang ^a   Wu, Ping ^b   Mills, Edward J ^b,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE TO HEALTH; CANCER RISK; CONTENT ANALYSIS; FEMALE; HEALTH PRACTITIONER; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; INFORMATION DISSEMINATION; MASS MEDIUM; MEDICAL INFORMATION; MENOPAUSAL SYNDROME; MENOPAUSE; OSTEOPOROSIS; PERCEPTION; PROPHYLAXIS; QUALITATIVE RESEARCH; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL BEHAVIOR; SYSTEMATIC REVIEW; DRUG EFFECT; ESTROGEN THERAPY; META ANALYSIS;

ESTROGEN;

ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENOPAUSE; PERCEPTION;

EID: 80052831988     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024661     Document Type: Review

References (69)

1. Hunt K, Vessey M, McPherson K, (1990) Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 97: 1080-1086.
2. Harlap S, (1992) The benefits and risks of hormone replacement therapy: an epidemiologic overview. Am J Obstet Gynecol 166: 1986-1992.
3. Mendelsohn ME, Karas RH, (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340: 1801-1811.
4. Canderelli R, Leccesse LA, Miller NL, Unruh Davidson J, (2007) Benefits of hormone replacement therapy in postmenopausal women. J Am Acad Nurse Pract 19: 635-641.
5. Huang KE, Xu L, I NN, Jaisamrarn U, (2010) The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 65: 276-283.
6. Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT, (1993) Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 168: 772-780.
7. Heinemann K, Rubig A, Strothmann A, Nahum GG, Heinemann LA, (2008) Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents. J Womens Health (Larchmt) 17: 1151-1166.
8. Hulley S, Grady D, Bush T, Furberg C, Herrington D, et al. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Jama 280: 605-613.
9. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama 288: 321-333.
10. International Heart Lung and Blood Institute. Available:http://wwwnhlbinihgov/about/factbook/chapter3htm.
11. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD, (2002) Postmenopausal hormone replacement therapy: scientific review. Jama 288: 872-881.
12. Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, et al. (2010) Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. Jama 304: 1684-1692.
13. Power ML, Anderson BL, Schulkin J, (2009) Attitudes of obstetrician-gynecologists toward the evidence from the Women's Health Initiative hormone therapy trials remain generally skeptical. Menopause 16: 500-508.
14. Fugh-Berman A, McDonald CP, Bell AM, Bethards CE, Scialli RA, (2011) Promotional Tone in Reviews of Menopausal Hormone Therapy After the Women's Health Initiative: An Analysis of Published Articles. PLoS Med 8: e100425.
15. Majumdar SR, Almasi EA, Stafford RS, (2004) Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative. Jama 292: 1983-1988.
16. Hoffmann M, Hammar M, Kjellgren KI, Lindh-Astrand L, Brynhildsen J, (2005) Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. Maturitas 52: 11-17.
17. Power ML, Zinberg S, Schulkin J, (2006) A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy. Menopause 13: 434-441.
18. Rolnick SJ, Jackson J, Kopher R, Defor TA, (2007) Provider management of menopause after the findings of the Women's Health Initiative. Menopause 14: 441-449.
19. Mills E, Cooper C, Guyatt G, Gilchrist A, Rachlis B, et al. (2004) Barriers to participating in an HIV vaccine trial: a systematic review. Aids 18: 2235-2242.
20. Mills EJ, Montori VM, Ross CP, Shea B, Wilson K, et al. (2005) Systematically reviewing qualitative studies complements survey design: an exploratory study of barriers to paediatric immunisations. J Clin Epidemiol 58: 1101-1108.
21. Mills EJ, Seely D, Rachlis B, Griffith L, Wu P, et al. (2006) Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 7: 141-148.
22. Mills E, Jadad AR, Ross C, Wilson K, (2005) Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. J Clin Epidemiol 58: 1081-1088.
23. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al. (2006) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 3: e438.
24. Maslove DM, Mnyusiwalla A, Mills EJ, McGowan J, Attaran A, et al. (2009) Barriers to the effective treatment and prevention of malaria in Africa: A systematic review of qualitative studies. BMC Int Health Hum Rights 9: 26.
25. Borenstein M, Hedges L, Higgins JP, Rothstein H, (2009) Introduction to Meta-analysis. Wiley, Chichester.
26. Freeman MF, Turkey JW, (1950) Transformations related to the angular and the square root. Ann Math Stat pp. 607-611.
27. Borenstein M, Hedges L, Higgins JP, Rothstein H, (2009) Introduction to Meta-analysis.
28. Lam PM, Leung TN, Haines C, Chung TK, (2003) Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years. Maturitas 45: 99-107.
29. Kaur S, Walia I, Singh A, (2004) How menopause affects the lives of women in suburban Chandigarh, India. Climacteric 7: 175-180.
30. Barber CA, Margolis K, Luepker RV, Arnett DK, (2004) The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002). J Womens Health (Larchmt) 13: 975-985.
31. Obermeyer CM, Reynolds RF, Price K, Abraham A, (2004) Therapeutic decisions for menopause: results of the DAMES project in central Massachusetts. Menopause 11: 456-465.
32. Ekstrom H, (2005) Trends in middle-aged women's reports of symptoms, use of hormone therapy and attitudes towards it. Maturitas 52: 154-164.
33. Filho AS, Soares JMJR, Arkader J, Maciel GA, Baracat EC, (2005) Attitudes and practices about postmenopausal hormone therapy among female gynecologists in Brazil. Maturitas 51: 146-153.
34. Hovi SL, Hakama M, Veerus P, Rahu M, Hemminki E, (2005) Who wants to join preventive trials?-Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]. BMC Med Res Methodol 5: 12.
35. Chaopotong P, Titapant V, Boriboonhirunsarn D, (2005) Menopausal symptoms and knowledge towards daily life and hormone replacement therapy among menopausal women in Bangkok. J Med Assoc Thai 88: 1768-1774.
36. Thunell L, Stadberg E, Milsom I, Mattsson LA, (2005) Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval. Acta Obstet Gynecol Scand 84: 395-401.
37. Bosworth HB, Bastian LA, Grambow SC, McBride CM, Skinner CS, et al. (2005) Initiation and discontinuation of hormone therapy for menopausal symptoms: results from a community sample. J Behav Med 28: 105-114.
38. Genazzani AR, Schneider HP, Panay N, Nijland EA, (2006) The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol 22: 369-375.
39. Sveinsdottir H, Olafsson RF, (2006) Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study. J Adv Nurs 54: 572-584.
40. Loutfy I, Abdel Aziz F, Dabbous NI, Hassan MH, (2006) Women's perception and experience of menopause: a community-based study in Alexandria, Egypt. East Mediterr Health J 12 (Suppl 2): S93-106.
41. Twiss JJ, Wegner J, Hunter M, Kelsay M, Rathe-Hart M, et al. (2007) Perimenopausal symptoms, quality of life, and health behaviors in users and nonusers of hormone therapy. J Am Acad Nurse Pract 19: 602-613.
42. Rigby AJ, Ma J, Stafford RS, (2007) Women's awareness and knowledge of hormone therapy post-Women's Health Initiative. Menopause 14: 853-858.
43. Uncu Y, Alper Z, Ozdemir H, Bilgel N, Uncu G, (2007) The perception of menopause and hormone therapy among women in Turkey. Climacteric 10: 63-71.
44. Castelo-Branco C, Ferrer J, Palacios S, Cornago S, Peralta S, (2007) Spanish post-menopausal women's viewpoints on hormone therapy. Maturitas 56: 420-428.
45. Lindh-Astrand L, Brynhildsen J, Hoffmann M, Liffner S, Hammar M, (2007) Attitudes towards the menopause and hormone therapy over the turn of the century. Maturitas 56: 12-20.
46. Lindh-Astrand L, Brynhildsen J, Hoffmann M, Kjellgren KI, Hammar M, (2007) Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women: a population-based study. Menopause 14: 1039-1046.
47. Deeks A, Zoungas S, Teede H, (2008) Risk perception in women: a focus on menopause. Menopause 15: 304-309.
48. Malik HS, (2008) Knowledge and attitude towards menopause and hormone replacement therapy (HRT) among postmenopausal women. J Pak Med Assoc 58: 164-167.
49. Donati S, Cotichini R, Mosconi P, Satolli R, Colombo C, et al. (2009) Menopause: knowledge, attitude and practice among Italian women. Maturitas 63: 246-252.
50. Huston SA, Jackowski RM, Kirking DM, (2009) Women's trust in and use of information sources in the treatment of menopausal symptoms. Womens Health Issues 19: 144-153.
51. Jassim GA, Al-Shboul QM, (2009) Knowledge of Bahraini women about the menopause and hormone therapy: implications for health-care policy. Climacteric 12: 38-48.
52. Simon JA, Reape KZ, (2009) Understanding the menopausal experiences of professional women. Menopause 16: 73-76.
53. Ballard K, (2002) Understanding risk: women's perceived risk of menopause-related disease and the value they place on preventive hormone replacement therapy. Fam Pract 19: 591-595.
54. Cifcili SY, Akman M, Demirkol A, Unalan PC, Vermeire E, (2009) "I should live and finish it": a qualitative inquiry into Turkish women's menopause experience. BMC Fam Pract 10: 2.
55. French LM, Smith MA, Holtrop JS, Holmes-Rovner M, (2006) Hormone therapy after the Women's Health Initiative: a qualitative study. BMC Fam Pract 7: 61.
56. Hepworth J, Paine B, Miles H, Marley J, MacLennan A, (2002) The willingness of women to participate in a long-term trial of hormone replacement therapy: A qualitative study using focus groups. Psychology, Health & Medicine 7: 469-476.
57. Hyde A, Nee J, Drennan J, Butler M, Howlett E, (2010) Hormone therapy and the medical encounter: a qualitative analysis of women's experiences. Menopause 17: 344-350.
58. Kolip P, Hoefling-Engels N, Schmacke N, (2009) Attitudes toward postmenopausal long-term hormone therapy. Qual Health Res 19: 207-215.
59. Nekhlyudov L, Bush T, Bonomi AE, Ludman EJ, Newton KM, (2009) Physicians' and women's views on hormone therapy and breast cancer risk after the WHI: a qualitative study. Women Health 49: 280-293.
60. Shelton AJ, Lees E, Groff JY, (2002) Perceptions of hormone replacement therapy among African American women. J Health Care Poor Underserved 13: 347-359.
61. Walter FM, Britten N, (2002) Patients' understanding of risk: a qualitative study of decision-making about the menopause and hormone replacement therapy in general practice. Fam Pract 19: 579-586.
62. Welton A, Hepworth J, Collins N, Ford D, Knott C, et al. (2004) Decision-making about hormone replacement therapy by women in England and Scotland. Climacteric 7: 41-49.
63. Huang KE, Xu L, I NN, Jaisamrarn U, (2010) The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 65: 276-283.
64. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. (2006) Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Jama 296: 679-690.
65. Pines A, Sturdee DW, Birkhauser MH, Schneider HP, Gambacciani M, et al. (2007) IMS updated recommendations on postmenopausal hormone therapy. Climacteric 10: 181-194.
66. Society CM, (2010) clinial guideline of hormone replacement therapy at the late menopusal transition and postmenopause. Chin J Obstet Gynecol 45: 635-638.
67. Allemand H, Seradour B, Weill A, Ricordeau P, (2008) [Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend]. Bull Cancer 95: 11-15.
68. Vankrunkelsven P, Kellen E, Lousbergh D, Cloes E, Op de Beeck L, et al. (2009) Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg. Breast Cancer Res Treat 118: 425-432.
69. Keelan J, Pavri-Garcia V, Tomlinson G, Wilson K, (2007) YouTube as a source of information on immunization: a content analysis. Jama 298: 2482-2484.